Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. First Quarter 2026 Overall Financial Performance
SOLV logo

Solventum Achieves 10.6% Adjusted EPS Growth Amid 3M Separation Challenges

SOLV8-KFiling Date: 5/5/2026
Solventum Corporation
Description

What this story covers

Solventum reported 2.1% organic sales growth and a 10.6% increase in adjusted EPS for Q1 2026. Despite heavy separation costs from 3M impacting GAAP results, management reaffirmed full-year guidance, signaling confidence in its independent operational momentum.

Story snapshot

CompanySolventum Corporation
TickerSOLV
VariantStandard detailed
Duration12:37
Filing type8-K
PeriodQ2 2026
IndustryHealthcare & Pharmaceuticals
Accession0001964738-26-000022
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in